Valerie Berlaimont
Waver, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact.
Journal: Human vaccines & immunotherapeutics
Published: December 17, 2024
Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries.
Journal: Human vaccines & immunotherapeutics
Published: April 27, 2023
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review.
Journal: Human vaccines & immunotherapeutics
Published: April 19, 2023
Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India.
Journal: Human vaccines & immunotherapeutics
Published: August 26, 2021
Hexavalent vaccines: What can we learn from head-to-head studies?
Journal: Vaccine
Published: March 16, 2021
Vaccination in preterm and low birth weight infants in India.
Journal: Human vaccines & immunotherapeutics
Published: February 18, 2021
Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules".
Journal: Human vaccines & immunotherapeutics
Published: August 19, 2020
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.
Journal: Human vaccines & immunotherapeutics
Published: January 18, 2020
Response to 'Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017' by Checchi et al.
Journal: Sexually transmitted infections
Published: April 24, 2019
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types.
Journal: Expert review of vaccines
Published: February 12, 2019
Letter-to-the-Editor in response to "Tanton C, et al. Human papillomavirus (HPV) in young women in Britain: Population-based evidence ofthe effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types. Papillomavirus Res. 2017 Jun;3:36-41.doi: 10.1016/j.pvr.2017.01.001."
Journal: Papillomavirus research (Amsterdam, Netherlands)
Published: October 27, 2017
Last Updated: 09/26/2026